The Board of Directors of Panacea Biotec Limited has at its meeting held today 13.11.2024 inter-alia considered and approved:1. Unaudited Standalone and Consolidated Financial Results (Provisional) for the quarter and half year ended 30.09.2024;2. Raising of funds by way of External Commercial Borrowings of an amount upto US$ 20 million (equivalent to ~Rs.168.16 Crore) from the U.S. International Development Finance Corporation;3.Appointment of Mr. Rajesh Jain Chartered Accountant as an additional director in the capacity of non-executive Independent Director for a term of 5 years w.e.f. 13.11.2024 subject to the approval of the shareholders; and4. Re-appointment of Dr. Rajesh Jain as Chairman and Managing Director liable to retire by rotation for a term of 3 years with effect from January 01 2025 subject to the approval of the shareholders.
Panacea Biotec: Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2024
13-Nov-2024
Download PDF
Panacea Biotec
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month